4//SEC Filing
Mast Therapeutics, Inc. 4
Accession 0001209191-13-033244
$SVRACIK 0001160308operating
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:09 PM ET
Size
5.9 KB
Accession
0001209191-13-033244
Insider Transaction Report
Form 4
Vetticaden Santosh
Chief Medical Officer & SVP
Transactions
- Award
Employee Stock Option (Right to Buy)
2013-06-19+125,000→ 125,000 totalExercise: $0.50Exp: 2023-06-19→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable as to 5,208 shares on September 5, 2013, which is the first anniversary of the reporting person's employment with the issuer, and as to approximately 1/48th of the balance of the shares subject to this option on October 5, 2013 and each monthly anniversary thereafter such that all of the shares subject to this option will have fully vested and become exercisable as of September 5, 2017, subject to continued service with the issuer.
Documents
Issuer
Mast Therapeutics, Inc.
CIK 0001160308
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001160308
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:09 PM ET
- Size
- 5.9 KB